The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
The odds for higher severity oral food challenge reactions did not significantly differ between patients on inhaled ...
_ A phase II multi-dose study shows fast-acting and long-lasting efficacy of LAS100977, Almirall_s novel once-daily inhaled beta2 agonist (LABA), for the treatment of bronchoconstriction in asthmatic ...
Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...
Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education. Administrative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results